{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:00:05Z","timestamp":1794027605806,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973338"],"award-info":[{"award-number":["81973338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFA0908004"],"award-info":[{"award-number":["2020YFA0908004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chronic neuropathic pain is a frequent sequel to peripheral nerve injury and maladaptive nervous system function. Divanillyl sulfone (DS), a novel structural derivative of 4,4\u2032-dihydroxydibenzyl sulfoxide from a traditional Chinese medicine\n                      <jats:italic>Gastrodia elata<\/jats:italic>\n                      with anti-nociceptive effects, significantly alleviated neuropathic pain following intrathecal injection. Here, we aimed to investigate the underlying mechanisms of DS against neuropathic pain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A chronic constrictive injury (CCI) mouse model of neuropathic pain induced by sciatic nerve ligation was performed to evaluate the effect of DS by measuring the limb withdrawal using Von Frey filament test. Immunofluorescence staining was used to assess the cell localizations and expressions of Iba-1, ASC, NLRP3, and ROS, the formation of autolysosome. The levels of NLRP3-related proteins (caspase-1, NLRP3, and IL-1\u03b2), mitophagy-related proteins (LC3, Beclin-1, and p62), and apoptosis-related proteins (Bcl-XL and Bax) were detected by Western blotting. The apoptosis of BV-2 cell and caspase activity were evaluated by flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DS significantly alleviated the neuropathic pain by increasing the mechanical withdrawal threshold and inhibiting the activation of NLRP3 in CCI-induced model mice. Our findings indicated that DS promoted the mitophagy by increasing the LC3II and Beclin 1 and decreasing the levels of p62 protein in BV-2 cell. This is accompanied by the inhibition of NLRP3 activation, which was shown as inhibited the expression of NLRP3 in lysates as well as the secretion of mature caspase-1 p10 and IL-1\u03b2 p17 in supernatants in cultured BV-2 microglia. In addition, DS could promote mitophagy-induced improvement of dysfunctional mitochondria by clearing intracellular ROS and restoring mitochondrial membrane potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Together, our findings demonstrated that DS ameliorate chronic neuropathic pain in mice by suppressing NLRP3 inflammasome activation induced by mitophagy in microglia. DS may be a promising therapeutic agent for chronic neuropathic pain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-021-02178-z","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T21:02:30Z","timestamp":1624482150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Shuai","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Na","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Lan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Tai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"issue":"1","key":"2178_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev-pharmtox-010611-134636","volume":"52","author":"HU Zeilhofer","year":"2012","unstructured":"Zeilhofer HU, Benke D, Yevenes GE. Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control. Annu Rev Pharmacol Toxicol. 2012;52(1):111\u201333 https:\/\/doi.org\/10.1146\/annurev-pharmtox-010611-134636.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"14","key":"2178_CR2","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1111\/bph.14580","volume":"176","author":"Z Bahari","year":"2019","unstructured":"Bahari Z, Meftahi GH. Spinal \u03b1 -adrenoceptors and neuropathic pain modulation; therapeutic target. Br J Pharmacol. 2019;176(14):2366\u201381 https:\/\/doi.org\/10.1111\/bph.14580.","journal-title":"Br J Pharmacol"},{"issue":"6312","key":"2178_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.aaf8933","volume":"354","author":"C Peirs","year":"2016","unstructured":"Peirs C, Seal RP. Neural circuits for pain: recent advances and current views. Science. 2016;354(6312):578\u201384 https:\/\/doi.org\/10.1126\/science.aaf8933.","journal-title":"Science."},{"issue":"1","key":"2178_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","volume":"126","author":"YJ Gao","year":"2010","unstructured":"Gao YJ, Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;126(1):56\u201368 https:\/\/doi.org\/10.1016\/j.pharmthera.2010.01.002.","journal-title":"Pharmacol Ther"},{"issue":"16","key":"2178_CR5","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.0501634102","volume":"102","author":"FY Tanga","year":"2005","unstructured":"Tanga FY, Nutile-McMenemy N, DeLeo JA. The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A. 2005;102(16):5856\u201361 https:\/\/doi.org\/10.1073\/pnas.0501634102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6312","key":"2178_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji RR, Chamessian A, Zhang YQ. Pain regulation by nonneuronal cells and inflammation. Science. 2016;354(6312):572\u20137 https:\/\/doi.org\/10.1126\/science.aaf8924.","journal-title":"Science."},{"key":"2178_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2014.02.001","volume":"258","author":"ET Walters","year":"2014","unstructured":"Walters ET. Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense. Exp Neurol. 2014;258:48\u201361 https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.001.","journal-title":"Exp Neurol"},{"issue":"11","key":"2178_CR8","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/14728222.2016.1214716","volume":"20","author":"YQ Zhou","year":"2016","unstructured":"Zhou YQ, Liu Z, Liu HQ, Liu DQ, Chen SP, Ye DW, et al. Targeting glia for bone cancer pain. Expert Opin Ther Targets. 2016;20(11):1365\u201374 https:\/\/doi.org\/10.1080\/14728222.2016.1214716.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"2178_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2012.11.007","volume":"36","author":"H Wake","year":"2013","unstructured":"Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 2013;36(4):209\u201317 https:\/\/doi.org\/10.1016\/j.tins.2012.11.007.","journal-title":"Trends Neurosci"},{"key":"2178_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.pain.2006.09.018","volume":"128","author":"A Moss","year":"2007","unstructured":"Moss A, Beggs S, Vega-Avelaira D, Costigan M, Hathway GJ, Salte MW, et al. Spinal microglia and neuropathic pain in young rats. Pain. 2007;128:215\u201324.","journal-title":"Pain."},{"issue":"11","key":"2178_CR11","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1523\/JNEUROSCI.2061-14.2015","volume":"35","author":"AK Clark","year":"2015","unstructured":"Clark AK, Gruber-Schoffnegger D, Drdla-Schutting R, Gerhold KJ, Malcangio M, Sandk\u00fchler J. Selective activation of microglia facilitates synaptic strength. J Neurosci. 2015;35(11):4552\u201370 https:\/\/doi.org\/10.1523\/JNEUROSCI.2061-14.2015.","journal-title":"J Neurosci"},{"key":"2178_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2017.01014","volume":"8","author":"Y Huh","year":"2017","unstructured":"Huh Y, Ji RR, Chen G. Neuroinflammation, bone marrow stem cells, and chronic pain. Front Immunol. 2017;8:1014 https:\/\/doi.org\/10.3389\/fimmu.2017.01014.","journal-title":"Front Immunol"},{"issue":"7","key":"2178_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd4334","volume":"13","author":"RR Ji","year":"2014","unstructured":"Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014;13(7):533\u201348 https:\/\/doi.org\/10.1038\/nrd4334.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"2178_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377 https:\/\/doi.org\/10.1038\/nri3705.","journal-title":"Nat Rev Immunol"},{"key":"2178_CR15","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1523\/JNEUROSCI.1238-16.2016","volume":"36","author":"H Kiyama","year":"2016","unstructured":"Kiyama H. TREM2\/DAP12 signal elicits proinflammatory response in microglia and exacerbates neuropathic pain. J Neurosci. 2016;36:11138\u201350.","journal-title":"J Neurosci"},{"key":"2178_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrn.2018.2","volume":"19","author":"K Inoue","year":"2019","unstructured":"Inoue K, Tsuda M. Microglia in neuropathic pain: cellular mechanisms and molecular therapeutic potential. Nat Rev Neurosci. 2019;19:138\u201352.","journal-title":"Nat Rev Neurosci"},{"key":"2178_CR17","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fphys.2020.01016","volume":"11","author":"H Starobova","year":"2020","unstructured":"Starobova H, Nadar EI, Vetter I. The NLRP3 Inflammasome: role and therapeutic potential in pain treatment. Front Physiol. 2020;11:1016 https:\/\/doi.org\/10.3389\/fphys.2020.01016.","journal-title":"Front Physiol"},{"key":"2178_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","volume":"16","author":"W He","year":"2019","unstructured":"He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, et al. Microglial NLRP3 inflammasome activation mediates IL-1beta release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation. 2019;16:78.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"2178_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","volume":"30","author":"C Jin","year":"2010","unstructured":"Jin C, Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol. 2010;30(5):628\u201331 https:\/\/doi.org\/10.1007\/s10875-010-9440-3.","journal-title":"J Clin Immunol"},{"issue":"1","key":"2178_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.12458","volume":"1319","author":"FS Sutterwala","year":"2014","unstructured":"Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 2014;1319(1):82\u201395 https:\/\/doi.org\/10.1111\/nyas.12458.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2178_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","volume":"60","author":"K Ren","year":"2009","unstructured":"Ren K, Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev. 2009;60(1):57\u201364 https:\/\/doi.org\/10.1016\/j.brainresrev.2008.12.020.","journal-title":"Brain Res Rev"},{"issue":"25","key":"2178_CR22","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","volume":"23","author":"B Viviani","year":"2003","unstructured":"Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 2003;23(25):8692\u2013700 https:\/\/doi.org\/10.1523\/JNEUROSCI.23-25-08692.2003.","journal-title":"J Neurosci"},{"issue":"20","key":"2178_CR23","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","volume":"28","author":"Y Kawasaki","year":"2008","unstructured":"Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008;28(20):5189\u201394 https:\/\/doi.org\/10.1523\/JNEUROSCI.3338-07.2008.","journal-title":"J Neurosci"},{"issue":"1","key":"2178_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","volume":"12","author":"G Schett","year":"2016","unstructured":"Schett G, Dayer JM, Manger B. Interleukin-1 function and role in the rheumatic disease. Nat Rev Rheumatol. 2016;12(1):14\u201324 https:\/\/doi.org\/10.1038\/nrrheum.2016.166.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2178_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo C, Fu R, Wang S, Huang Y, Li X, Zhou M, et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2018;194(2):231\u201343 https:\/\/doi.org\/10.1111\/cei.13167.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2178_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","volume":"17","author":"C Choulaki","year":"2015","unstructured":"Choulaki C, Papadaki G, Repa A, Kampouraki E, Kambas K, Ritis K, et al. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):257 https:\/\/doi.org\/10.1186\/s13075-015-0775-2.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2178_CR27","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1136\/ard.2009.108936","volume":"68","author":"R Terkeltaub","year":"2009","unstructured":"Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis. 2009;68(10):1613\u20137 https:\/\/doi.org\/10.1136\/ard.2009.108936.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2178_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","volume":"265","author":"SM Man","year":"2015","unstructured":"Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265(1):6\u201321 https:\/\/doi.org\/10.1111\/imr.12296.","journal-title":"Immunol Rev"},{"issue":"6","key":"2178_CR29","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Mu\u00f1oz-Planillo","year":"2013","unstructured":"Mu\u00f1oz-Planillo R, Kuffa P, Mart\u00ednez-Col\u00f3n G, Smith BL, Rajendiran TM, N\u00fa\u00f1ez G. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38(6):1142\u201353 https:\/\/doi.org\/10.1016\/j.immuni.2013.05.016.","journal-title":"Immunity."},{"issue":"1","key":"2178_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","volume":"265","author":"EI Elliott","year":"2015","unstructured":"Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265(1):35\u201352 https:\/\/doi.org\/10.1111\/imr.12286.","journal-title":"Immunol Rev"},{"issue":"18","key":"2178_CR31","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00018-012-0962-0","volume":"69","author":"A Salminen","year":"2012","unstructured":"Salminen A, Ojala J, Kaarniranta K, Kauppinen A. Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol Life Sci. 2012;69(18):2999\u20133013 https:\/\/doi.org\/10.1007\/s00018-012-0962-0.","journal-title":"Cell Mol Life Sci"},{"key":"2178_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5483\/BMBRep.2016.49.10.115","volume":"49","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Yoon JH, Ryu JH. Mitophagy: a balance regulator of NLRP3 inflammasome activation. BMB Rep. 2019;49:529\u201335.","journal-title":"BMB Rep"},{"key":"2178_CR33","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.bbagen.2013.08.014","volume":"1840","author":"KE Lawlor","year":"2014","unstructured":"Lawlor KE, Vince JE. Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria? Biochim Biophys Acta. 2014;1840:1433\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"2178_CR34","doi-asserted-by":"publisher","first-page":"100836","DOI":"10.1016\/j.mam.2019.100836","volume":"71","author":"LHM Bozi","year":"2020","unstructured":"Bozi LHM, Campos JC, Zambelli VO, Ferreira ND, Ferreira JCB. Mitochondrially-targeted treatment strategies. Mol Asp Med. 2020;71:100836 https:\/\/doi.org\/10.1016\/j.mam.2019.100836.","journal-title":"Mol Asp Med"},{"issue":"7329","key":"2178_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135 https:\/\/doi.org\/10.1038\/nature09663.","journal-title":"Nature."},{"issue":"4","key":"2178_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF02980077","volume":"27","author":"MK Pyo","year":"2004","unstructured":"Pyo MK, Jin JL, Koo YK, Yun-Choi HS. Phenolic and furan type compounds isolated from Gastrodia elata and their anti-platelet effects. Arch Pharm Res. 2004;27(4):381\u20135 https:\/\/doi.org\/10.1007\/BF02980077.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"2178_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"QY Li","year":"2018","unstructured":"Li QY, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225\u201342 https:\/\/doi.org\/10.1038\/nri.2017.125.","journal-title":"Nat Rev Immunol"},{"key":"2178_CR38","doi-asserted-by":"publisher","first-page":"174480691879593","DOI":"10.1177\/1744806918795930","volume":"14","author":"C Liu","year":"2018","unstructured":"Liu C, Zhang Y, Liu Q, Jiang L, Li M, Wang S, et al. P2X4-receptor participates in EAAT3 regulation via BDNF-TrkB signaling in a model of trigeminal allodynia. Mol Pain. 2018;14:174480691879593 https:\/\/doi.org\/10.1177\/1744806918795930.","journal-title":"Mol Pain"},{"key":"2178_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5238730","volume":"2016","author":"AM Jurga","year":"2016","unstructured":"Jurga AM, Rojewska E, Piotrowska A, Makuch W, Pilat D, Przewlocka B, et al. Blockade of toll-like receptors (TLR2, TLR4) attenuates pain and potentiates buprenorphine analgesia in a rat neuropathic pain model. Neural Plast. 2016;2016:1\u201312 https:\/\/10.1155\/2016\/5238730.","journal-title":"Neural Plast"},{"key":"2178_CR40","doi-asserted-by":"publisher","first-page":"101560","DOI":"10.1016\/j.redox.2020.101560","volume":"34","author":"Q Liu","year":"2020","unstructured":"Liu Q, Su LY, Sun C, Jiao L, Miao Y, Xu M, et al. Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation. Redox Biol. 2020;34:101560 https:\/\/doi.org\/10.1016\/j.redox.2020.101560.","journal-title":"Redox Biol"},{"issue":"3","key":"2178_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.celrep.2016.06.018","volume":"16","author":"N Gu","year":"2016","unstructured":"Gu N, Peng J, Murugan M, Wang X, Eyo UB, Sun D, et al. Spinal microgliosis due to resident microglial proliferation is required for pain hypersensitivity after peripheral nerve injury. Cell Rep. 2016;16(3):605\u201314 https:\/\/doi.org\/10.1016\/j.celrep.2016.06.018.","journal-title":"Cell Rep"},{"issue":"3","key":"2178_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0306-4522(00)00110-X","volume":"98","author":"P Honore","year":"2000","unstructured":"Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 2000;98(3):585\u201398 https:\/\/doi.org\/10.1016\/S0306-4522(00)00110-X.","journal-title":"Neuroscience."},{"key":"2178_CR43","doi-asserted-by":"publisher","first-page":"174480691987138","DOI":"10.1177\/1744806919871381","volume":"15","author":"L Kun","year":"2019","unstructured":"Kun L, Lu L, Yongda L, Xingyue L, Guang H. Hyperbaric oxygen promotes mitophagy by activating CaMKK\/AMPK signal pathway in rats of neuropathic pain. Mol Pain. 2019;15:1744806919871381 https:\/\/doi.org\/10.1177\/1744806919871381.","journal-title":"Mol Pain"},{"key":"2178_CR44","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/JPR.S198730","volume":"12","author":"MH Yi","year":"2019","unstructured":"Yi MH, Shin J, Shin N, Yin Y, Lee SY, Kim CS, et al. PINK1 mediates spinal cord mitophagy in neuropathic pain. J Pain Res. 2019;12:1685\u201399 https:\/\/doi.org\/10.2147\/JPR.S198730.","journal-title":"J Pain Res"},{"issue":"14","key":"2178_CR45","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/glia.20871","volume":"57","author":"K Inoue","year":"2009","unstructured":"Inoue K, Tsuda M. Microglia and neuropathic pain. Glia. 2009;57(14):1469\u201379 https:\/\/doi.org\/10.1002\/glia.20871.","journal-title":"Glia."},{"issue":"6","key":"2178_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15(6):556\u20139 https:\/\/doi.org\/10.1038\/s41589-019-0277-7.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2178_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/imr.12908","volume":"297","author":"D Chauhan","year":"2020","unstructured":"Chauhan D, Vande Walle L, Lamkanfi M. Therapeutic modulation of inflammasome pathways. Immunol Rev. 2020;297(1):123\u201338 https:\/\/doi.org\/10.1111\/imr.12908.","journal-title":"Immunol Rev"},{"key":"2178_CR48","doi-asserted-by":"publisher","first-page":"102515","DOI":"10.1016\/j.jaut.2020.102515","volume":"113","author":"N Zhao","year":"2020","unstructured":"Zhao N, Li CC, Di B, Xu LL. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors. J Autoimmun. 2020;113:102515 https:\/\/doi.org\/10.1016\/j.jaut.2020.102515.","journal-title":"J Autoimmun"},{"issue":"4","key":"2178_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"DJ Klionsky","year":"2012","unstructured":"Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445\u2013544 https:\/\/doi.org\/10.4161\/auto.19496.","journal-title":"Autophagy."},{"issue":"6","key":"2178_CR50","first-page":"781","volume":"22","author":"P Gim\u00e9nez-Xavier","year":"2008","unstructured":"Gim\u00e9nez-Xavier P, Francisco R, Platini F, P\u00e9rez R, Ambrosio S. LC3-I conversion to LC3-II does not necessarily result in complete autophagy. Int J Mol Med. 2008;22(6):781\u20135.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2178_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bph.12935","volume":"172","author":"SM Cheng","year":"2015","unstructured":"Cheng SM, Chang YC, Liu CY, Lee JY, Chan HH, Kuo CW, et al. YM155 downregulates surviving and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells. Br J Pharmacol. 2015;172(1):214\u201334 https:\/\/doi.org\/10.1111\/bph.12935.","journal-title":"Br J Pharmacol"},{"key":"2178_CR52","doi-asserted-by":"publisher","first-page":"7215","DOI":"10.1038\/ncomms8215","volume":"6","author":"T Sun","year":"2014","unstructured":"Sun T, Li X, Zhang P, Chen WD, Zhang HL, Li DD, et al. Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumor growth. Nat Commun. 2014;6:7215 https:\/\/doi.org\/10.1038\/ncomms8215.","journal-title":"Nat Commun"},{"key":"2178_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yjmcc.2015.10.032","volume":"95","author":"Y Maejima","year":"2016","unstructured":"Maejima Y, Isobe M, Sadoshima J. Regulation of autophagy by Beclin 1 in the heart. J Mol Cell Cardiol. 2016;95:19\u201325 https:\/\/doi.org\/10.1016\/j.yjmcc.2015.10.032.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"2178_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18(4):571\u201380 https:\/\/doi.org\/10.1038\/cdd.2010.191.","journal-title":"Cell Death Differ"},{"issue":"2","key":"2178_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/15548627.2019.1607686","volume":"16","author":"A Thangaraj","year":"2019","unstructured":"Thangaraj A, Periyasamy P, Guo ML, Chivero ET, Callen S, Buch S. Mitigation of cocaine-mediated mitochondrial damage, defective mitophagy and microglial activation by superoxide dismutase mimetics. Autophagy. 2019;16(2):289\u2013312 https:\/\/doi.org\/10.1080\/15548627.2019.1607686.","journal-title":"Autophagy."},{"key":"2178_CR56","doi-asserted-by":"publisher","first-page":"8639618","DOI":"10.1155\/2019\/8639618","volume":"2019","author":"JS Ye","year":"2019","unstructured":"Ye JS, Chen L, Lu YY, Lei SQ, Peng M, Xia ZY. Honokiol-mediated mitophagy ameliorates postoperative cognitive impairment induced by surgery\/sevoflurane via inhibiting the activation of NLRP3 inflammasome in the hippocampus. Oxidative Med Cell Longev. 2019;2019:8639618 https:\/\/doi.org\/10.1155\/2019\/8639618.","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"2178_CR57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.2215","volume":"13","author":"CS Shi","year":"2012","unstructured":"Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, et al. Activation of autophagy by inflammatory signals limits IL-1\u03b2production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012;13(3):255\u201363 https:\/\/doi.org\/10.1038\/ni.2215.","journal-title":"Nat Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02178-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02178-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02178-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:06:38Z","timestamp":1675479998000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02178-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2178"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02178-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.All animals were treated in accordance with the International Guidelines for animal research. All experimental procedures involving animals were approved by the Experimental Animal Care and Use Committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}